why choose us

Clinical Trials Search

Showing 10,080 of 132,366 result(s)
Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry

Status: Completed

Condition: Liver Transplant

Interventions: The TransMedics® Organ Care System (OCSTM) Liver is an FDA approved portable extracorporeal liver perfusion and monitoring system.

Date: 2023-06-29

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

Status: Completed

Condition: Gestational Diabetes

Interventions: acetylcholine is perfused at 10 ascending concentrations (10^-10M - 10^-1 M) for 5 minutes each

Date: 2023-06-29

ACP-Family Programme for Palliative Care Patients and Their Family Member

Status: Completed

Condition: Palliative Care

Interventions:

It consists of two sessions (45-60 mins) to be delivered within one month in a face-to-face format as long as the patient is still in the hospital.

Date: 2023-06-29

High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers

Status: COMPLETED

Condition: Aortic Stenosis

Interventions: Use of High-flow nasal oxygen at 60% 50 L;min.

Date: 2023-06-29

Safety and Efficacy of MBF-118 in Patients with Crohn Disease

Status: COMPLETED

Condition: Crohn Disease

Interventions: MBF-118 oral capsules PPAR gamma receptor partial agonist

Date: 2023-06-29

Dose Expansion, Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Status: Completed

Condition: Non-muscle Invasive Bladder Cancer

Interventions:

Cohort A: All subjects will receive 6 weekly instillations of TARA-002 at the established recommended Phase 2 dose (RP2D).
Subjects who are el

Date: 2023-06-29

Pulmonary Hypertension in Left Heart Disease

Status: Completed

Condition: Pulmonary Hypertension

Interventions: Transthoracic echocardiography using ultrasound waves will be conducted during the rest and exercise phases of the clinically indicated invasive hemod

Date: 2023-06-29

A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator With a Skincare Regimen

Status: Completed

Condition: Photodamaged Skin

Interventions: Biostimulator and cosmetics

Date: 2023-06-29

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Status: Completed

Condition: Uveitis Posterior Non-Infectious

Interventions: Oral tablet

Date: 2023-06-29

Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery

Status: Completed

Condition: Substance Use Disorders

Interventions: 4 in-person sessions; 1 individual and 3 group sessions

Date: 2023-06-29